ClinicalTrials.gg
RecruitingNCT07322276SLEEPCOREUpdated Jun 3, 2026

Effects of Exercise Timing on Sleep Quality

An interventional study of Aerobic Exercise in Healthy Endurance Athlet and Inactive People, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Recruiting at 1 site in France. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 76 studies in Sleep Initiation and Maintenance Disorders with a site in France — 19 open to participants now, 19 under way, 1 of them phase 3. Sleep Initiation and Maintenance Disorders · France.

Planned enrollment
48th of 60
42 · median 69
Started
2026
with 4 others
No phase
37 of 76
12 open now
Primary completion
2029-01
later than 17 of 18 live
Registered
70th of 76
by date

Among the 76 studies in Sleep Initiation and Maintenance Disorders with a site in France, this one is the 48th largest by planned enrollment of the 60 interventional ones that give a count, is one of 5 that started in 2026, is one of 37 with no phase, reaches primary completion later than 17 of the 18 other live ones, and was the 70th registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

19 of the 76 studies in Sleep Initiation and Maintenance Disorders with a site in France are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years to 30 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 76 studies in Sleep Initiation and Maintenance Disorders with a site in France, or all of them as a file.
02

Study summary

Modern lifestyles are marked by a prevalence of sedentary behaviors and physical inactivity, which have been linked to numerous adverse health effects. While regular physical exercise is a well-established countermeasure, exercising in the late afternoon may paradoxically disrupt deep sleep due to increased core body temperature. Inactive and sedentary individuals, who often have impaired autonomic function compared to endurance-trained athletes, may be particularly susceptible to these negative effects, potentially resulting in compromised thermoregulation and exacerbated disruptions to deep sleep, a critical stage of sleep essential for overall recovery. Therefore, this study aims to investigate the impact of aerobic exercise performed in the late afternoon versus morning on: 1) deep sleep and sleep onset latency; and 2) core body temperature and its autonomic regulatory mechanisms on endurance-trained and inactive-sedentary people.

03

Conditions studied

  • Healthy Endurance Athlet
  • Inactive People

Keywords

  • endurance athletes
  • exercise timing
  • sleep quality
04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Group "Inactive" :No regular exercise practice (inactive people that don't follow the WHO recommendations) and have sedentary behaviors
  • Group "Active": Regular exercise (athletes that are specialized in aerobic exercise, with more than 300 minutes per-week over 6 months and practice at regional level).

Exclusion criteria

Exclusion Criteria:

  • Have sleep disorders medically diagnosed or detected by sleep forms cutoffs (clinical insomnia by ISI, severe risk of obstructive sleep apnea by Stop-Bang, bad sleep quality by PSQI.
  • Have a diagnosed mental health condition requiring treatment
  • Have renal, respiratory, cardiovascular or neuromuscular disease medically diagnosed.
  • Be pregnant or breastfeeding
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
42 participants (estimated)

Study arms

  • Active comparator
    "Inactive-sedentary" group

    inactive participants that realize 3 experimental conditions: evening exercise, morning exercise and control (no-exercise).

    Other: Aerobic Exercise

  • Experimental
    "Active" group

    endurance athletes that realize 3 experimental conditions: evening exercise, morning exercise and control (no-exercise).

    Other: Aerobic Exercise

Interventions

  • OtherAerobic Exercise

    The exercise consists of running on a treadmill at 90% of maximum aerobic speed (MAS) for 30 minutes, followed by 12% increments every 5 minutes, until exhaustion (a "time-to-exhaustion" type of exercise).

06

What researchers measure

Primary outcomes

  1. Duration of deep slow-wave sleep

    Evaluation of the duration of deep slow-wave sleep (N3 stage) quantified by the EEG signal from polysomnography (Nox A1, Resmed®, USA).

    Time frame: Once a month for 3 months

Secondary outcomes

  1. Assessment of core temperature

    Assessment of core temperature until the end of the sleep period will be measured using gastrointestinal telemetric pills (eCelsius, Bodycap®, France).

    Time frame: Once a month for 3 months

  2. Evaluation of autonomic nervous system thermoregulation

    Evaluation of autonomic nervous system thermoregulation through time-domain (R-R intervals in ms)

    Time frame: Once a month for 3 months

  3. Evaluation of autonomic nervous system thermoregulation

    Evaluation of autonomic nervous system thermoregulation through frequency- domain parameters (in Hz)

    Time frame: Once a month for 3 months

  4. Complementary sleep evaluation

    Complementary sleep evaluation through analysis of duration of N1, N2, and REM stages (in Percentage of Total Sleep Time)

    Time frame: Once a month for 3 months

  5. Complementary sleep evaluation

    Complementary sleep evaluation through characteristics of slow waves present in N3 (amplitude in microvolts)

    Time frame: Once a month for 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — This study is realized only in St-Etienne university Hospital

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jan 2029, 36 months after the start.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 36 months is above that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 21, 2025
First posted
Jan 7, 2026
StartActual
Jan 23, 2026
Primary completionEst.
Jan 31, 2029
CompletionEst.
May 31, 2029
Last update
Jun 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07322276
Responsible party
Sponsor
First posted
Jan 7, 2026
Start date
Jan 23, 2026
Primary completion
Jan 31, 2029 (estimated)
Completion
May 31, 2029 (estimated)
Last update
Jun 3, 2026

Study contacts

Frédéric ROCHE, PhD
Contact
frederic.roche@univ-st-etienne.fr
0477828695 ext. 33
Frédéric ROCHE, PhD
principal investigator · Centre Hospitalier Universitaire de Saint Etienne

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion